NEW RIVER PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · VA · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
FDA-approved drugs
openFDA · most recent- PROFERDEXMar 26, 1981
- DOXEPIN HYDROCHLORIDEJan 31, 1972
- TRIAVIL 4-25Aug 23, 1965
Material events
SEC Form 8-K · most recent- Delisting / listing-standard notice · Change in control · Director / officer change · Amended charter or bylaws · Other material eventApr 24, 2007
- Other material eventApr 6, 2007
- Results of operationsMar 14, 2007
- Other material eventFeb 26, 2007
- Entered a material agreement · Other material eventFeb 23, 2007
- Other material eventFeb 6, 2007
- Entered a material agreementJan 29, 2007
- Other material eventDec 22, 2006
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KApr 24, 2007
- SC 13D/AApr 20, 2007
- S-8 POSApr 19, 2007
- 15-12GApr 19, 2007
- 25-NSEApr 19, 2007
- SC 13D/AApr 18, 2007
- SC 14D9/ANEW RIVER PHARMACEUTICALS SC 14D-9/A 4-17-2007Apr 18, 2007
- SC TO-T/AApr 18, 2007
- SC 14D9/ANEW RIVER PHARMACEUTICALS SC14D 9A 3 4-16-2007Apr 16, 2007
- SC TO-T/AApr 16, 2007
- 8-KNEW RIVER PHARMACEUTICALS INC. 8-K 4-3-2007Apr 6, 2007
- SC 13DMar 29, 2007
- SC 14D9/ANEW RIVER PHARMACEUTICALS SC14D/A 2 03-26-2007Mar 26, 2007
- SC TO-T/AMar 26, 2007
- SC 14D9/ANEW RIVER PHARMACEUTICALS SC 14D9 A1 3-16-2007Mar 19, 2007